Results 141 to 150 of about 31,922 (243)

Lymphatic Endothelial Cells in Health and Disease

MedComm, Volume 7, Issue 8, August 2026.
Lymphatic endothelial cells (LECs) are dynamic regulators of tissue homeostasis and disease remodeling. In the healthy state, LECs coordinate interstitial fluid drainage, intestinal lipid transport, and immune trafficking and tolerance. Across disease settings, however, these same programs become maladaptively reprogrammed, contributing to barrier ...
Du Tang, Wang Lin, Hengyang Liu, Jixin Zhong, Shiliang Li, Xiaoquan Rao   +5 more
wiley   +1 more source

Diagnostic performance and clinical limitations of sentinel lymph node biopsy in head and neck melanoma: a 20-year retrospective cohort study. [PDF]

J Cancer Res Clin Oncol
Lükewille L, Wiegand S, Fazel A, Kähler KC, Radecker G, Hoffmann M, within the HANSEATIC Head and Neck Oncology Collaboration.   +6 more
europepmc   +1 more source

Sentinel Lymph Node [PDF]

, 2020
openaire   +1 more source

Restriction‐Weighted Q‐Space Trajectory Imaging (ResQ): Toward Mapping Diffusion‐Time Effects With Tensor‐Valued Diffusion Encoding in Human Prostate Cancer Xenografts

NMR in Biomedicine, Volume 39, Issue 8, August 2026.
Tensor‐valued diffusion MRI enables microstructure characterization but can be confounded by the presence of restricted diffusion. We introduce ResQ, a framework that incorporates restriction weighting into q‐space trajectory imaging and we evaluate it in a longitudinal study of prostate cancer xenografts treated by external radiotherapy. ResQ revealed
Filip Szczepankiewicz, Malwina Molendowska, Samo Lasič, Marcella E. Safi, Michael Gottschalk, Evangelia Sereti, Anders Bjartell, Linda Knutsson, Oskar Vilhelmsson Timmermand, Crister Ceberg, Joanna Strand   +10 more
wiley   +1 more source

Para-Aortic Lymph Node Metastasis Detected by Sentinel Lymph Node Biopsy in Cervical Cancer Initially Presumed to be Stage IA2: A Case Report. [PDF]

J Obstet Gynaecol Res
Ouchi H, Chiyoda T, Sakai K, Shiraishi Y, Nishio H, Yamagami W.   +5 more
europepmc   +1 more source

Efficacy of Adjuvant Interferon‐β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study

The Journal of Dermatology, Volume 53, Issue 8, Page 1124-1132, August 2026.
ABSTRACT Nail apparatus melanoma (NAM) is a biologically and clinically distinct subtype of melanoma; however, the efficacy of adjuvant interferon (IFN) therapy in this population remains unclear. We conducted a multicenter retrospective study to compare adjuvant IFN‐β (adj‐IFN) with observation (OBS) in patients with resected stage IIB, IIC, or III ...
Takaya Komori, Eiji Nakano, Yukiko Kiniwa, Shoichiro Mori, Sotaro Yamamoto, Hiroshi Kato, Shusuke Yoshikawa, Koji Yoshino, Megumi Aoki, Tatsuya Takenouchi, Takuya Maeda, Keijun Yoshino, Shuichi Ohe, Kenta Nakama, Hideyuki Ishikawa, Yoshiyuki Nakamura, Toshihiro Takai, Takamichi Ito, Hiroshi Kitagawa, Hiraku Kokubu, Naohito Hatta, Takeru Funakoshi, Toshihiko Hoashi, Takayuki Suyama, Susumu Fujiwara, Mamiko Masuzawa, Hiroshi Uchi, Takuya Miyagawa, Soichiro Kado, Yuki Yamamoto, Jun Asai, Junji Kato, Taku Maeda, Natsuki Baba, Yukihiko Kato, Kohei Oashi, Takeo Maekawa, Shunichi Jinnai, Aya Nishizawa, Ko Kagoyama, Atsushi Otsuka, Katsuhiko Nishihara, Dai Ogata, Kenjiro Namikawa, Yasuhiro Nakamura, Shigeto Matsushita   +45 more
wiley   +1 more source

Tumor Thickness and Histological Grade as Determinants of Sentinel Lymph Node Metastasis in Cutaneous Squamous Cell Carcinoma. [PDF]

Medicina (Kaunas)
Janković I, Stevanović G, Kovačević T, Janković D, Pavlović D.   +4 more
europepmc   +1 more source

Standardization of postoperative adverse event reporting: A critical opportunity for improvement within the National Clinical Trials Network

Cancer, Volume 132, Issue 15, 1 August 2026.
Beth Helmink, Matthew H. G. Katz, Chandrajit P. Raut, Sumithra J. Mandrekar, Kristina Laumann, Allison Booth, Laura Hoffman, Eric A. Singer, Isabelle Bedrosian, Rebecca A. Snyder   +9 more
wiley   +1 more source

Outcomes for Patients With Micro‐Invasive or Small HER2+ Breast Cancer in Northern Sydney Local Health District

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 4, Page 564-572, August 2026.
This retrospective study of patients with small, node‐negative HER2+ breast cancer found favorable 5‐year invasive disease‐free survival rates—93% for pT1mic/a disease and 100% for pT1b disease. Trastuzumab was administered to 66% of patients and was associated with larger tumor size and higher histologic grade.
Yuanyuan Xue, Katrina Moore, Tricia Saurine, David Chan, Lina Pugliano, Connie Diakos   +5 more
wiley   +1 more source

Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node-Negative Microinvasive DCIS. [PDF]

Breast J
Huang C, Parmar P, Habboosh N, Bhimani F, Chen Y, Entenberg D, Oktay M, Gupta A, Pastoriza J, McEvoy M, Feldman S.   +10 more
europepmc   +1 more source